Date: 2015-04-14
Type of information: Establishment of a new subsidiary in the EU
Compound:
Company: Incyte (USA - DE)
Therapeutic area: Cancer - Oncology - Rare diseases
Type agreement: establishment of a new subsidiary in the EU
Action mechanism:
Disease:
Details: * On April 14, 2015, Incyte announced that it will establish the new headquarters of Incyte Europe S.a.r.l (\"Incyte Europe\") in Geneva, Switzerland. Incyte intends to use Incyte Europe as the base from which it will conduct its European clinical development operations, and expects to occupy the 9,000 sq. ft. facility by mid-2015.
Financial terms:
Latest news:
